Baker McKenzie advised ATB Therapeutics SA on the deal. ATB Therapeutics SA, a Belgian next-generation antibody company, completed a EUR 54 million Series A financing. The...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Aurelius on the deal, Advant Nctm assisted Blue Torch Finance LLC, and Norton Rose Fulbright Studio Legale represented Wells Fargo Bank, National Association,...
You must be a Standard 1 Year member to access this content.
Addleshaw Goddard advised JD Sports Fashion plc on the deal, while Baker McKenzie advised AURELIUS on the deal. The sale has been agreed in accordance with...
You must be a Standard 1 Year member to access this content.
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised AURELIUS on the transaction. Gilbert + Tobin, working closely with Orica’s M&A and legal teams, acted for Orica. Orica (ASX: ORI) announced the...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Modag GmbH on the deal. Blomstein advised Teva Pharmaceutical Industries Limited. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Numab Therapeutics on the deal. Numab Therapeutics closed a CHF 100 million (approximately USD 110 million) Series C financing. Numab Therapeutics is a clinical...
You must be a Standard 1 Year member to access this content.
